Yiming Mu

12.1k total citations · 3 hit papers
326 papers, 5.1k citations indexed

About

Yiming Mu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Yiming Mu has authored 326 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Endocrinology, Diabetes and Metabolism, 100 papers in Surgery and 84 papers in Molecular Biology. Recurrent topics in Yiming Mu's work include Diabetes Treatment and Management (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers) and Diabetes Management and Research (40 papers). Yiming Mu is often cited by papers focused on Diabetes Treatment and Management (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers) and Diabetes Management and Research (40 papers). Yiming Mu collaborates with scholars based in China, United States and Philippines. Yiming Mu's co-authors include Weidong Han, Yu Cheng, Jiejie Liu, Haojie Hao, Jingtao Dou, Li Zang, Anping Wang, Weijun Gu, Juming Lu and Kang Chen and has published in prestigious journals such as JAMA, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yiming Mu

307 papers receiving 5.0k citations

Hit Papers

Prevalence of obesity and associated complications in Chi... 2023 2026 2024 2025 2023 2023 2024 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
    2023 175 citations Kang Chen, Zewei Shen et al. Diabetes Obesity and Metabolism profile →
  2. Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
    2023 84 citations Ildiko Lingvay, André Gustavo Daher Vianna et al. profile →
  3. Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
    2024 59 citations Yiming Mu, Ning Zu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiming Mu China 35 2.2k 1.6k 1.3k 886 680 326 5.1k
Moon‐Kyu Lee South Korea 35 1.4k 0.6× 1.4k 0.9× 916 0.7× 1.1k 1.3× 163 0.2× 154 4.2k
Pedro Iglesias Spain 35 2.5k 1.2× 751 0.5× 723 0.6× 1.3k 1.5× 249 0.4× 219 4.9k
Saula Vigili de Kreutzenberg Italy 39 1.3k 0.6× 842 0.5× 2.0k 1.6× 682 0.8× 369 0.5× 115 5.3k
Carlo Sabbà Italy 46 693 0.3× 1.7k 1.0× 1.5k 1.2× 1.3k 1.4× 1.1k 1.7× 211 6.7k
Steven D. Mittelman United States 40 866 0.4× 834 0.5× 1.4k 1.1× 745 0.8× 395 0.6× 104 4.8k
Chan Soo Shin South Korea 45 1.1k 0.5× 1.4k 0.8× 2.1k 1.6× 622 0.7× 334 0.5× 217 6.2k
Wei Mu China 40 1.0k 0.5× 873 0.5× 1.6k 1.3× 1.1k 1.2× 211 0.3× 78 6.1k
Yangang Wang China 30 1.2k 0.5× 711 0.4× 1.1k 0.8× 463 0.5× 272 0.4× 138 3.7k
Jae Hyeon Kim South Korea 39 2.9k 1.3× 1.7k 1.0× 981 0.8× 1.1k 1.2× 97 0.1× 280 5.7k
Bernhard Paulweber Austria 45 1.2k 0.6× 1.0k 0.6× 2.1k 1.7× 1.5k 1.7× 212 0.3× 171 6.0k

Countries citing papers authored by Yiming Mu

Since Specialization
Citations

This map shows the geographic impact of Yiming Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Mu more than expected).

Fields of papers citing papers by Yiming Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Mu. The network helps show where Yiming Mu may publish in the future.

Co-authorship network of co-authors of Yiming Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Mu. A scholar is included among the top collaborators of Yiming Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Mu. Yiming Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Philis‐Tsimikas, Athena, Jens Aberle, Harpreet S. Bajaj, et al.. (2025). Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management. Drugs. 85(10). 1253–1268.
2.
Gu, Weijun, Yibing Lu, Guoyue Yuan, et al.. (2025). Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial. Diabetes Obesity and Metabolism. 27(5). 2540–2551. 2 indexed citations
3.
Zhang, Peng, Yaqi Yin, Jie Li, et al.. (2025). Long-term cardiometabolic outcomes of primary bilateral macronodular adrenal hyperplasia. Journal of Endocrinological Investigation. 48(6). 1403–1414.
4.
5.
Ji, Linong, Yiming Mu, Cuiqing Chang, et al.. (2024). Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION ‐China study. Diabetes Obesity and Metabolism. 26(10). 4694–4704. 6 indexed citations
6.
7.
Li, Binqi, Xin Zhou, Weiqing Wang, et al.. (2024). Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations. Journal of Diabetes. 16(8). e13596–e13596. 5 indexed citations
8.
Lin, Lu, Anping Wang, Haibin Wang, et al.. (2023). High hemoglobin glycation index is associated with increased risk of diabetes: A population-based cohort study in China. Frontiers in Endocrinology. 14. 1081520–1081520. 10 indexed citations
9.
Li, Binqi, Xin Zhou, Weiqing Wang, et al.. (2023). Remnant cholesterol is independently associated with diabetes, even if the traditional lipid is at the appropriate level: A report from the REACTION study. Journal of Diabetes. 15(3). 204–214. 8 indexed citations
10.
Wu, Jiong, Jian Zhang, Yue Du, et al.. (2023). 686P Phase I study of HRS8807, an oral selective ER covalent antagonist (SERCA), in ER+/HER2- locally advanced (LA) or metastatic (M) breast cancer (BC). Annals of Oncology. 34. S479–S479. 2 indexed citations
11.
Liu, Hongyan, Guoqi Wang, Jian Zhao, et al.. (2023). Association of skin autofluorescence with depressive symptoms and the severity of depressive symptoms: The prospective REACTION study. Psychoneuroendocrinology. 154. 106285–106285. 1 indexed citations
12.
13.
Zeng, Jinyang, Yulong Chen, Pei Yu, et al.. (2022). Clinical analysis of the etiological spectrum of bilateral adrenal lesions: A large retrospective, single-center study. Endocrine. 77(2). 372–379. 4 indexed citations
14.
15.
Li, Wei, Anping Wang, Jiajia Jiang, et al.. (2020). Risk of chronic kidney disease defined by decreased estimated glomerular filtration rate in individuals with different prediabetic phenotypes: results from a prospective cohort study in China. BMJ Open Diabetes Research & Care. 8(1). e000955–e000955. 9 indexed citations
16.
Wen, Jing, Anping Wang, Guangxu Liu, et al.. (2020). Elevated triglyceride-glucose (TyG) index predicts incidence of Prediabetes: a prospective cohort study in China. Lipids in Health and Disease. 19(1). 54 indexed citations
17.
18.
Yang, Shanshan, et al.. (2018). Association between the Hypertriglyceridemic Waist Phenotype and Prediabetes in Chinese Adults Aged 40 Years and Older. Journal of Diabetes Research. 2018. 1–9. 14 indexed citations
19.
Dou, Jingtao, et al.. (2016). [Etiology analysis of 522 hospitalized cases with Cushing syndrome].. PubMed. 96(31). 2454–7. 2 indexed citations
20.
Lü, Zhaohui, Guoqing Yang, Jing–tao Dou, et al.. (2013). Clinical characteristic analysis of 742 hospitalized cases with type 1 diabetes mellitus. 5(2). 89–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moon‐Kyu Lee Breakdown of academic impact, for papers by Pedro Iglesias Breakdown of academic impact, for papers by Saula Vigili de Kreutzenberg Breakdown of academic impact, for papers by Carlo Sabbà Breakdown of academic impact, for papers by Steven D. Mittelman Breakdown of academic impact, for papers by Chan Soo Shin Breakdown of academic impact, for papers by Wei Mu Breakdown of academic impact, for papers by Yangang Wang Breakdown of academic impact, for papers by Jae Hyeon Kim Breakdown of academic impact, for papers by Bernhard Paulweber
Rankless by CCL
2026